Latest Posts
The latest guides, provider updates, and clinical news on GLP-1 injections — reviewed by clinicians and updated weekly.
Life After Retatrutide: The Maintenance Question
Key Takeaways This article is explicitly theoretical and extrapolative. No retatrutide-specific discontinuation trial has been published as of July 2026. Everything here about stopping…
Retatrutide and Muscle Mass: Lean Tissue Preservation Data
Key Takeaways This article summarizes published body composition research for informational purposes. It is not exercise or nutrition medical advice, and it…
Retatrutide and Sleep Apnea: TRIUMPH-1 OSA Basket Results
Key Takeaways This article discusses nested trial data and comparative research findings for informational purposes. It is not a treatment recommendation and…
Preparing for Retatrutide: What to Know Before Approval
Key Takeaways This article is intended to help readers understand the general landscape of obesity-medication access and administrative preparation. It is not…
Retatrutide 104-Week Data: Does Weight Loss Plateau?
Key Takeaways This article discusses published and topline clinical trial data for informational purposes. It is not a promise of individual results…
TRANSCEND-T2D-1: Retatrutide for Type 2 Diabetes
Key Takeaways This article summarizes published trial data for informational purposes. Retatrutide is not approved to treat type 2 diabetes or any…
TRIUMPH-4 Trial: Retatrutide for Obesity and Knee Osteoarthritis
Key Takeaways TRIUMPH-4 findings are described here for informational purposes only. Retatrutide has not been approved for any indication. On December 11,…
TRIUMPH-1 Trial Results Explained (May 21, 2026)
Key Takeaways TRIUMPH-1 results are presented here for informational purposes. Retatrutide is investigational and not an approved treatment. On May 21, 2026,…
Retatrutide vs Semaglutide: Triple vs Single Agonist
Key Takeaways This is a comparison of published trial data, not a recommendation of one drug over another. Retatrutide remains investigational. Among…
Retatrutide vs Tirzepatide: Head-to-Head Weight Loss Comparison
Key Takeaways This article compares publicly reported trial data. It does not recommend one treatment over the other and is not medical…
Retatrutide and Heart Rate: What TRIUMPH-1 Reported
Key Takeaways Heart rate changes are a well-documented, class-wide characteristic of GLP-1 receptor agonist medications, and retatrutide — as a triple hormone…
Dysesthesia and Retatrutide: The Unique Nerve-Sensation Signal
Key Takeaways Among the various side effects reported in retatrutide’s Phase 3 program, one stands out as genuinely novel within the weight-loss…
Retatrutide Discontinuation Rates: How Tolerable Is It?
Key Takeaways Tolerability — not just efficacy — determines whether a weight-loss medication succeeds in the real world. A drug that produces…
Retatrutide and Nausea: What Phase 3 Data Shows
Key Takeaways Nausea is, by a wide margin, the side effect people ask about most when researching GLP-1-class weight-loss medications — and…
Retatrutide Side Effects: Complete 2026 Safety Profile
Key Takeaways Retatrutide is one of the most closely watched investigational obesity drugs of 2026, largely because of the weight-loss magnitude reported…
The Retatrutide Titration Schedule from TRIUMPH-1
Key Takeaways This article describes a dose-escalation pattern used in a specific clinical trial for educational purposes. It is not instructional guidance…
Retatrutide Injection Schedule: Once-Weekly Subcutaneous Explained
Key Takeaways This article explains administration methods used in clinical research settings. It does not provide instructions for self-administration, and retatrutide is…
Retatrutide vs Single & Dual Agonists: Why 3 Receptors Matter
Key Takeaways This article compares mechanisms and trial-reported outcomes for educational purposes. It is not a recommendation for any specific treatment, dose,…
How Retatrutide Works: The Triple Agonist Mechanism (GIP + GLP-1 + Glucagon)
Key Takeaways This article is a scientific explainer, not a treatment guide. Retatrutide’s mechanism is described here for educational purposes and does…
Retatrutide Dosing Explained: 1mg to 12mg Titration
Key Takeaways This article discusses doses studied in clinical trials for research and educational purposes. It is not a prescribing guide, and…